EPIX ESSA Pharma Inc. gains 138% Jan 27, 2021

Posted By: Rajesh Srivastava - Wednesday, January 27, 2021

Share

& Comment

ESSA Pharma Inc., a clinical-stage pharmaceutical company, focuses on the development of novel and proprietary therapies for the treatment of prostate cancer. Its product candidate is EPI-506, an oral small molecule pro-drug that blocks the N-terminal domain of the androgen receptor. The company was founded in 2009 and is headquartered in Vancouver, Canada.http://www.priceseries.com/trade/EPIX-ESSA-Pharma-Inc-stock-gains-138-percent-a-Trade-Record-by-priceSeries-2020121020210127.html

About Rajesh Srivastava

Techism is an online Publication that complies Bizarre, Odd, Strange, Out of box facts about the stuff going around in the world which you may find hard to believe and understand. The Main Purpose of this site is to bring reality with a taste of entertainment

0 comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Copyright © priceSeries Daily Results™ is a registered trademark.

Designed by Templateism. Hosted on Blogger Platform.